Cargando…

Sanguisorba officinalis L. enhances the 5-fluorouracil sensitivity and overcomes chemoresistance in 5-fluorouracil-resistant colorectal cancer cells via Ras/MEK/ERK and PI3K/Akt pathways

Sanguisorba officinalis L., a traditional Chinese medicine (TCM) called DiYu (DY) in China, has a strong tradition of utilization as a scorching, blood-cooling, and hemostatic medication, and was used for cancer prevention and treatment due to its potential immune-enhancing and hematological toxicit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Weijia, Ou, Ling, Peng, Chang, Sang, Shuyi, Feng, Zhong, Zou, Yuanjing, Yuan, Yuemei, Li, Hao, Zhang, Guimin, Yao, Meicun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360953/ https://www.ncbi.nlm.nih.gov/pubmed/37484409 http://dx.doi.org/10.1016/j.heliyon.2023.e16798

Ejemplares similares

A Bioactive Compound from Sanguisorba officinalis L. Inhibits Cell Proliferation and Induces Cell Death in 5-Fluorouracil-Sensitive/Resistant Colorectal Cancer Cells
por: Zhang, Weijia, et al.
Publicado: (2021)

Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of Sanguisorba officinalis Against Colorectal Cancer
por: Zhang, Weijia, et al.
Publicado: (2022)

In vitro anti‐bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection
por: Shen, Xue, et al.
Publicado: (2021)

Sanguisorba officinalis L synergistically enhanced 5-fluorouracil cytotoxicity in colorectal cancer cells by promoting a reactive oxygen species-mediated, mitochondria-caspase-dependent apoptotic pathway
por: Liu, Meng-ping, et al.
Publicado: (2016)

Evaluation of Polyphenolic Composition and Antimicrobial Properties of Sanguisorba officinalis L. and Sanguisorba minor Scop.
por: Tocai (Moţoc), Alexandra-Cristina, et al.
Publicado: (2022)

Modulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance
por: Chun, Kyung-Soo, et al.
Publicado: (2022)

MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism
por: Pereira, Diane M., et al.
Publicado: (2016)

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989)

The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy
por: Chen, Jian, et al.
Publicado: (2021)

Terpene Glycosides from Sanguisorba officinalis and Their Anti-Inflammatory Effects
por: Guo, Da-Le, et al.
Publicado: (2019)

Simultaneous Determination and Pharmacokinetics Study of Six Triterpenes in Rat Plasma by UHPLC-MS/MS after Oral Administration of Sanguisorba officinalis L. Extract
por: Wu, Chengcui, et al.
Publicado: (2018)

Hyperammonemia Secondary to 5-Fluorouracil
por: Scott, Ashley, et al.
Publicado: (2023)

Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2(+) Breast Cancer Cells to 5-Fluorouracil
por: Yi, Jianing, et al.
Publicado: (2020)

Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
por: Zhang, Sheng, et al.
Publicado: (2019)

Enhanced Vasculogenic Capacity Induced by 5-Fluorouracil Chemoresistance in a Gastric Cancer Cell Line
por: Peri, Sara, et al.
Publicado: (2021)

Terpene Glycosides from the Roots of Sanguisorba officinalis L. and Their Hemostatic Activities
por: Sun, Wei, et al.
Publicado: (2012)

Chemical Composition, Antioxidant and Antimicrobial Activities of Sanguisorba officinalis L. Extracts
por: Gawron-Gzella, Anna, et al.
Publicado: (2016)

Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors
por: Merchant, Mark, et al.
Publicado: (2017)

MEK inhibitor enhanced the antitumor effect of oxaliplatin and 5-fluorouracil in MEK1 Q56P-mutant colorectal cancer cells
por: Jing, Changwen, et al.
Publicado: (2019)

HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway
por: Xu, Xi, et al.
Publicado: (2018)

Participation of CCL1 in Snail-Positive Fibroblasts in Colorectal Cancer Contribute to 5-Fluorouracil/Paclitaxel Chemoresistance
por: Li, Ziqian, et al.
Publicado: (2018)

Chemoresistance of colorectal cancer to 5-fluorouracil is associated with silencing of the BNIP3 gene through aberrant methylation
por: He, Jianming, et al.
Publicado: (2017)

Bioavailability and feasibility of subcutaneous 5-fluorouracil.
por: Borner, M. M., et al.
Publicado: (1993)

5-fluorouracil and cardiotoxicity: a review
por: Sara, Jaskanwal D., et al.
Publicado: (2018)

5-Fluorouracil-induced vasospastic angina
por: Ayyildiz, Orhan, et al.
Publicado: (2005)

5-Fluorouracil Rechallenge After Cardiotoxicity
por: Desai, Aakash, et al.
Publicado: (2020)

Fluorouracil (5-FU)-induced Cardiomyopathy
por: Thalambedu, Nishanth, et al.
Publicado: (2019)

Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines
por: Shiga, Taro, et al.
Publicado: (2020)

5-Fluorouracil–Induced Coronary Vasospasm
por: Arya, Sumedha, et al.
Publicado: (2018)

Efficacy of 5-Fluorouracil in the Treatment of Pterygium
por: Shah, Sobia U, et al.
Publicado: (2021)

5-Fluorouracil Cardiotoxicity: Known But Unknown
por: Brell, Joanna M.
Publicado: (2021)

Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
por: Chau, I, et al.
Publicado: (2001)

Pharmacokinetic Modulation of Plasma 5‐Fluorouracil Concentrations to Potentiate the Antitumor Activity of Continuous Venous Infusion of 5‐Fluorouracil
por: Fujii, Setsuro, et al.
Publicado: (1989)

A Comparative Study of the Efficacy of Intralesional 5 Fluorouracil vs Combination of 5 Fluorouracil with Triamcinolone Acetonide in Keloids
por: Monteiro, Rochelle C, et al.
Publicado: (2022)

Efficacy of Topical 5% 5-Fluorouracil with Needling versus 5% 5-Fluorouracil Alone in Stable Vitiligo: A Randomized Controlled Study
por: Zahra, Fatima T., et al.
Publicado: (2020)

Bioactivity-guided isolation and identification of anti-adipogenic compounds from Sanguisorba officinalis
por: Im, Sun Hyuk, et al.
Publicado: (2017)

Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors
por: Merchant, Mark, et al.
Publicado: (2018)

Porokeratoma treated with topical 5% 5-fluorouracil cream
por: Li, Steve S., et al.
Publicado: (2021)

Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
por: Peters, G. J., et al.
Publicado: (1989)

Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer
por: Borro, Marina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kuuq2tjqsrqdbu7h3buqd3nkcv